| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bionik Laboratories Corp. | Director, 10%+ Owner | Common Stock, par value $0.001 per share | 4.92M | $2.95M | $0.60 | 13 Jun 2023 | Shares held through GD Holdings and Lombard International Assurance SA |
| Bionik Laboratories Corp. | Director, 10%+ Owner | Common Stock, par value $0.001 per share | 61.3K | $36.8K | $0.60 | 13 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BNKL | Bionik Laboratories Corp. | 13 Jun 2023 | 1 | $1.86M | 4 | Director, 10%+ Owner | 21 Jun 2023, 10:59 |
| BNKL | Bionik Laboratories Corp. | 09 Jun 2023 | 1 | $108K | 4 | Director, 10%+ Owner | 21 Jun 2023, 10:57 |
| BNKL | Bionik Laboratories Corp. | 31 Mar 2022 | 1 | $740K | 4 | Director, 10%+ Owner | 21 Jun 2022, 17:47 |
| BNKL | Bionik Laboratories Corp. | 15 Jul 2021 | 4 | $0 | 4 | Director, 10%+ Owner | 13 Dec 2021, 15:32 |
| BNKL | Bionik Laboratories Corp. | 29 Mar 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 13 Dec 2021, 15:31 |
| BNKL | Bionik Laboratories Corp. | 26 Mar 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 13 Dec 2021, 15:30 |